Researchers have used NK92 cells to bring drug-loaded nanoparticles to a solid tumor and block inhibitory signals in the TME (166), and local delivery of chemoattractants such as CCL20 or CXCL16 can increase tumor infiltration by ILCs (167). Here, CXCL16 is linked to neoplasm.